ARCHIVES

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

This article is from The Cancer Letter archive.

Vol. 31 No. 01 | January 7, 2005

Download PDF Visit The Full Archive

Related Articles

Power’s Offer to Write Report On NCAB’s Organ Systems Decision Declined By DeVita

June 15, 1984

Undeterred By Randomized Trial Results, AUA Calls For Baseline PSA At Age 40.

May 1, 2009

New Task Force For Nutrition Research Urged By NCAB Committee

February 19, 1982

ASCO Supports CT Scans For Colorectal Screening

November 25, 2005

Xgeva Delays Metastases To Bone, Amgen Files To Expand Indication

November 25, 2011

Obit: Fred Rapp, Penn State Dean And Virologist, Dead At 72.

April 6, 2001